• All motifs sorted by activity significance
• All samples sorted alphabetically
• Mean activities

• Activities table
• Activity deltas table
• Regulatory interactions
• Motifs sorted by significance (text)
• Download the whole report

Motif ID: MZF1.p2

Z-value: 2.702

---

Top targets:

Promoter	Score	Refseq	Gene Symbol	Gene Name
chr9_+_108665168	7.560	NM_021224	ZNF462	zinc finger protein 462
chr18_-_22382497	6.039	NM_001142730	KCTD1	potassium channel tetramerisation domain containing 1
chr8_+_22513043	4.099	NM_001013842 NM_001198827 NM_173686	C8orf58	chromosome 8 open reading frame 58
chr13_+_113574925	3.963	NM_001143945	GAS6	growth arrest-specific 6
chr10_-_105604942	3.596	NM_014631	SH3PXD2A	SH3 and PX domains 2A
chr4_-_158111916	3.079		PDGFC	platelet derived growth factor C
chr13_-_39075200	3.011		LHFP	lipoma HMGIC fusion partner
chr4_-_158111995	2.977	NM_016205	PDGFC	platelet derived growth factor C
chr4_-_11039600	2.940	NM_005114	HS3ST1	heparan sulfate (glucosamine) 3-O-sulfotransferase 1
chrX_-_1291526	2.929	NM_001012288 NM_022148	CRLF2	cytokine receptor-like factor 2
chr15_+_66658626	2.517	NM_006091	CORO2B	coronin, actin binding protein, 2B
chr5_+_17270474	2.433	NM_006317	BASP1	brain abundant, membrane attached signal protein 1
chr7_-_27136876	2.373	NM_002141	HOXA4	homeobox A4
chr1_-_72521079	2.347
chr21_-_27261276	2.335	NM_007038	ADAMTS5	ADAM metallopeptidase with thrombospondin type 1 motif, 5
chr11_-_68537243	2.332	NM_001098515 NM_145015	MRGPRF	MAS-related GPR, member F
chr13_-_43259032	2.183	NM_017993	ENOX1	ecto-NOX disulfide-thiol exchanger 1
chr5_+_92944680	2.177	NM_005654	NR2F1	nuclear receptor subfamily 2, group F, member 1
chr11_+_61352209	2.158	NM_004265	FADS2	fatty acid desaturase 2
chr6_-_10523203	2.157		TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
chr3_-_189354510	2.147		LOC339929	hypothetical LOC339929
chr6_-_75972473	2.093		COL12A1	collagen, type XII, alpha 1
chr17_-_20886680	2.038	NM_015276	USP22	ubiquitin specific peptidase 22
chr11_+_61352348	2.037		FADS2	fatty acid desaturase 2
chr1_+_2975590	2.026	NM_022114 NM_199454	PRDM16	PR domain containing 16
chr8_-_11096257	2.009	NM_173683	XKR6	XK, Kell blood group complex subunit-related family, member 6
chr6_-_72187168	1.965		C6orf155	chromosome 6 open reading frame 155
chr12_-_51912101	1.949	NM_000966	RARG	retinoic acid receptor, gamma
chrX_-_74062005	1.930	NM_001008537	KIAA2022	KIAA2022
chr10_+_119292699	1.928
chr3_+_195889845	1.927		FAM43A	family with sequence similarity 43, member A
chr16_-_71650034	1.920	NM_001164766	ZFHX3	zinc finger homeobox 3
chr4_+_145786622	1.884	NM_022475	HHIP	hedgehog interacting protein
chrX_+_12066505	1.824	NM_014728	FRMPD4	FERM and PDZ domain containing 4
chr5_-_92942680	1.819		FLJ42709	hypothetical LOC441094
chr9_+_33807213	1.808		UBE2R2	ubiquitin-conjugating enzyme E2R 2
chr20_+_8060762	1.806	NM_015192 NM_182734	PLCB1	phospholipase C, beta 1 (phosphoinositide-specific)
chr11_-_132318741	1.804		OPCML	opioid binding protein/cell adhesion molecule-like
chr13_-_39075355	1.789	NM_005780	LHFP	lipoma HMGIC fusion partner
chr20_+_19141282	1.764	NM_020689	SLC24A3	solute carrier family 24 (sodium/potassium/calcium exchanger), member 3
chr12_+_74071145	1.746	NM_152436	GLIPR1L2	GLI pathogenesis-related 1 like 2
chr9_-_4289574	1.729		GLIS3	GLIS family zinc finger 3
chr1_-_72520735	1.725	NM_173808	NEGR1	neuronal growth regulator 1
chr9_+_8848130	1.720
chr2_-_174537021	1.712	NM_001017371	SP3	Sp3 transcription factor
chr4_-_158111504	1.681		PDGFC	platelet derived growth factor C
chr11_+_131286513	1.670		NTM	neurotrimin
chrX_+_73557809	1.668	NM_006517	SLC16A2	solute carrier family 16, member 2 (monocarboxylic acid transporter 8)
chr10_-_79067210	1.654		KCNMA1	potassium large conductance calcium-activated channel, subfamily M, alpha member 1
chr13_-_39075304	1.640		LHFP	lipoma HMGIC fusion partner
chr12_+_74071116	1.627		GLIPR1L2	GLI pathogenesis-related 1 like 2
chr12_-_52179462	1.607	NM_001193511 NM_006301	MAP3K12	mitogen-activated protein kinase kinase kinase 12
chr4_+_183302105	1.593		ODZ3	odz, odd Oz/ten-m homolog 3 (Drosophila)
chr3_+_189354167	1.572	NM_001167672	LPP	LIM domain containing preferred translocation partner in lipoma
chr3_+_98016114	1.550	NM_001080448	EPHA6	EPH receptor A6
chr12_+_64504835	1.549		HMGA2	high mobility group AT-hook 2
chr5_+_82803248	1.532	NM_001126336 NM_001164097 NM_001164098 NM_004385	VCAN	versican
chr14_+_85069217	1.516
chr6_-_10520592	1.513	NM_001032280	TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
chr4_-_115120251	1.507	NM_024590	ARSJ	arylsulfatase family, member J
chr2_+_69093641	1.504	NM_018153 NM_032208 NM_053034	ANTXR1	anthrax toxin receptor 1
chr12_-_6585785	1.489		CHD4	chromodomain helicase DNA binding protein 4
chr6_-_10523424	1.484	NM_003220	TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
chr12_+_52653176	1.482	NM_014212	HOXC11	homeobox C11
chr12_-_116890410	1.481	NM_173598	KSR2	kinase suppressor of ras 2
chr18_-_55515623	1.479	NM_133459	CCBE1	collagen and calcium binding EGF domains 1
chr4_-_86106567	1.477	NM_014991	WDFY3	WD repeat and FYVE domain containing 3
chr8_+_30361485	1.472	NM_001008710 NM_001008711 NM_001008712 NM_006867	RBPMS	RNA binding protein with multiple splicing
chr5_+_129268352	1.464	NM_175856	CHSY3	chondroitin sulfate synthase 3
chr10_-_103593529	1.450	NM_014591 NM_173191 NM_173192 NM_173193 NM_173195 NM_173197	KCNIP2	Kv channel interacting protein 2
chr19_-_13478037	1.417	NM_000068 NM_001127221 NM_001127222 NM_001174080 NM_023035	CACNA1A	calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
chr12_+_56406296	1.417		LOC100130776	hypothetical LOC100130776
chr18_-_55515552	1.407		CCBE1	collagen and calcium binding EGF domains 1
chr5_-_9599157	1.406	NM_003966	SEMA5A	sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
chr17_-_44047299	1.405	NM_024016	HOXB8	homeobox B8
chr21_+_46226072	1.404	NM_001848	COL6A1	collagen, type VI, alpha 1
chr11_+_124539814	1.395		PKNOX2	PBX/knotted 1 homeobox 2
chr9_+_136673534	1.393		COL5A1	collagen, type V, alpha 1
chr22_-_28972683	1.380	NM_002309	LIF	leukemia inhibitory factor (cholinergic differentiation factor)
chr1_-_212791597	1.370	NM_005401	PTPN14	protein tyrosine phosphatase, non-receptor type 14
chr1_-_29321599	1.355	NM_001171868	TMEM200B	transmembrane protein 200B
chr4_+_37569093	1.355	NM_015173	TBC1D1	TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
chr10_-_33663984	1.342		NRP1	neuropilin 1
chr8_+_123863224	1.340		ZHX2	zinc fingers and homeoboxes 2
chr19_-_41215380	1.335		CLIP3	CAP-GLY domain containing linker protein 3
chr20_+_19141364	1.323		SLC24A3	solute carrier family 24 (sodium/potassium/calcium exchanger), member 3
chr8_+_121206478	1.305	NM_021110	COL14A1	collagen, type XIV, alpha 1
chr12_-_131816604	1.302		ANKLE2	ankyrin repeat and LEM domain containing 2
chr6_-_10520264	1.293		TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
chr3_-_121652183	1.285	NM_007085	FSTL1	follistatin-like 1
chr8_+_120497732	1.284	NM_002514	NOV	nephroblastoma overexpressed gene
chr22_-_26527469	1.283	NM_002430	MN1	meningioma (disrupted in balanced translocation) 1
chr2_-_216944911	1.281	NM_020814	MARCH4	membrane-associated ring finger (C3HC4) 4
chr10_-_79067296	1.273		KCNMA1	potassium large conductance calcium-activated channel, subfamily M, alpha member 1
chr4_+_30330963	1.272	NM_001173523 NM_002589 NM_032456 NM_032457	PCDH7	protocadherin 7
chr5_-_159478967	1.267	NM_001130864 NM_052927	PWWP2A	PWWP domain containing 2A
chr17_-_24068759	1.265	NM_001144942 NM_031934	RAB34	RAB34, member RAS oncogene family
chr2_+_209996913	1.262	NM_001039538	MAP2	microtubule-associated protein 2
chr12_-_6668880	1.256	NM_001039917 NM_001039919 NM_001039920 NM_001135734	ZNF384	zinc finger protein 384
chr2_-_61551403	1.237		USP34	ubiquitin specific peptidase 34
chr19_-_53365371	1.233	NM_000234	LIG1	ligase I, DNA, ATP-dependent
chrX_-_103060777	1.229		LOC100128594	hypothetical LOC100128594
chr12_-_6668680	1.228		ZNF384	zinc finger protein 384
chr7_-_27120015	1.225		HOXA3	homeobox A3
chr9_+_2611740	1.219	NM_001018056 NM_003383	VLDLR	very low density lipoprotein receptor
chr5_-_127901633	1.203	NM_001999	FBN2	fibrillin 2
chr10_+_71231693	1.198		COL13A1	collagen, type XIII, alpha 1
chr2_-_127580975	1.194	NM_004305 NM_139343 NM_139344 NM_139345 NM_139346 NM_139347 NM_139348 NM_139349 NM_139350 NM_139351	BIN1	bridging integrator 1
chr2_-_161058120	1.191		RBMS1	RNA binding motif, single stranded interacting protein 1
chr17_-_24069299	1.185	NM_001142624 NM_001142625 NM_001144943	RAB34	RAB34, member RAS oncogene family
chr19_-_36531958	1.185	NM_020856	TSHZ3	teashirt zinc finger homeobox 3
chr2_-_110230642	1.184		MALL	mal, T-cell differentiation protein-like
chr7_-_19123765	1.179		TWIST1	twist homolog 1 (Drosophila)
chr3_-_121445831	1.174	NM_001168271 NM_153002	GPR156	G protein-coupled receptor 156
chr2_+_5750229	1.174	NM_003108	SOX11	SRY (sex determining region Y)-box 11
chr11_+_8059267	1.171	NM_177972	TUB	tubby homolog (mouse)
chr16_-_3225360	1.167	NM_001145448 NM_198088 NM_001145446 NM_198087	ZNF200	zinc finger protein 200
chr6_+_17389752	1.165	NM_001143942	RBM24	RNA binding motif protein 24
chr3_+_152287365	1.163	NM_053002	MED12L	mediator complex subunit 12-like
chr20_+_17498507	1.163	NM_001011546 NM_006870	DSTN	destrin (actin depolymerizing factor)
chr10_-_33663777	1.162	NM_001024628 NM_001024629 NM_003873	NRP1	neuropilin 1
chr9_+_2612134	1.158		VLDLR	very low density lipoprotein receptor
chr4_-_96689137	1.155		UNC5C	unc-5 homolog C (C. elegans)
chr12_-_93568336	1.152	NM_020698	TMCC3	transmembrane and coiled-coil domain family 3
chr9_+_2612099	1.151		VLDLR	very low density lipoprotein receptor
chr2_-_110230822	1.147		MALL	mal, T-cell differentiation protein-like
chr3_-_151904408	1.139	NM_152394	FAM194A	family with sequence similarity 194, member A
chr16_-_63713485	1.132		CDH11	cadherin 11, type 2, OB-cadherin (osteoblast)
chr18_+_17076166	1.131	NM_001142966	GREB1L	growth regulation by estrogen in breast cancer-like
chr15_-_86600658	1.127	NM_001007156 NM_001012338 NM_002530	NTRK3	neurotrophic tyrosine kinase, receptor, type 3
chr7_+_55054152	1.127	NM_005228 NM_201282 NM_201283 NM_201284	EGFR	epidermal growth factor receptor
chr16_+_31390567	1.124	NM_001042454 NM_001164719	TGFB1I1	transforming growth factor beta 1 induced transcript 1
chr2_-_197883569	1.123		ANKRD44	ankyrin repeat domain 44
chr17_+_58058783	1.116		MRC2	mannose receptor, C type 2
chr3_+_106568243	1.111		ALCAM	activated leukocyte cell adhesion molecule
chr1_-_56817823	1.102	NM_003713	PPAP2B	phosphatidic acid phosphatase type 2B
chr5_-_111120929	1.100	NM_001142482 NM_001142481	C5orf13	chromosome 5 open reading frame 13
chr9_-_10602722	1.097	NM_002839	PTPRD	protein tyrosine phosphatase, receptor type, D
chr6_+_127481740	1.090	NM_032784	RSPO3	R-spondin 3 homolog (Xenopus laevis)
chr14_-_62581656	1.089	NM_139318 NM_172375	KCNH5	potassium voltage-gated channel, subfamily H (eag-related), member 5
chr10_-_76829857	1.074		ZNF503	zinc finger protein 503
chr7_-_127458231	1.069	NM_022143	LRRC4	leucine rich repeat containing 4
chr11_+_124539768	1.068	NM_022062	PKNOX2	PBX/knotted 1 homeobox 2
chr12_-_105056577	1.068		NUAK1	NUAK family, SNF1-like kinase, 1
chr9_+_2612052	1.061		VLDLR	very low density lipoprotein receptor
chr4_+_30331289	1.061		PCDH7	protocadherin 7
chr8_+_32525269	1.058	NM_001160002 NM_001160004 NM_001160005 NM_001160007 NM_001160008 NM_004495 NM_013956 NM_013957 NM_013958 NM_013960 NM_013964	NRG1	neuregulin 1
chr10_-_79067400	1.056		KCNMA1	potassium large conductance calcium-activated channel, subfamily M, alpha member 1
chr2_-_75641535	1.056		FAM176A	family with sequence similarity 176, member A
chr9_-_4290028	1.051	NM_001042413	GLIS3	GLIS family zinc finger 3
chr5_-_111120764	1.043		C5orf13	chromosome 5 open reading frame 13
chr1_+_181259317	1.039
chr17_+_7096095	1.038	NM_203415 NM_015362 NM_203413 NM_203414	C17orf81	chromosome 17 open reading frame 81
chr3_+_182113125	1.038		FXR1	fragile X mental retardation, autosomal homolog 1
chr13_+_87122778	1.035	NM_015567	SLITRK5	SLIT and NTRK-like family, member 5
chr16_-_63713466	1.033		CDH11	cadherin 11, type 2, OB-cadherin (osteoblast)
chr2_-_158440587	1.032	NM_001111067	ACVR1	activin A receptor, type I
chr18_-_27518392	1.025	NM_004775	B4GALT6	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6
chr19_-_11352850	1.023		EPOR	erythropoietin receptor
chr18_-_22383066	1.020	NM_001136205	KCTD1	potassium channel tetramerisation domain containing 1
chr11_-_27697768	1.016	NM_001143807	BDNF	brain-derived neurotrophic factor
chr10_-_79067476	1.014		KCNMA1	potassium large conductance calcium-activated channel, subfamily M, alpha member 1
chr18_-_24010944	1.007		CDH2	cadherin 2, type 1, N-cadherin (neuronal)
chr9_+_33807590	1.007		UBE2R2	ubiquitin-conjugating enzyme E2R 2
chr11_+_17714070	1.004	NM_001112741 NM_004976	KCNC1	potassium voltage-gated channel, Shaw-related subfamily, member 1
chr7_+_78920846	0.995		LOC100505881	hypothetical LOC100505881
chr1_-_194844299	0.994		KCNT2	potassium channel, subfamily T, member 2
chr2_-_75641587	0.988	NM_001135032	FAM176A	family with sequence similarity 176, member A
chr12_-_6668787	0.987	NM_001039918 NM_133476	ZNF384	zinc finger protein 384
chr2_-_56004366	0.986	NM_001039348 NM_001039349	EFEMP1	EGF containing fibulin-like extracellular matrix protein 1
chr7_+_114349376	0.983	NM_001166345 NM_001166346 NM_199072	MDFIC	MyoD family inhibitor domain containing
chr16_-_63713382	0.981	NM_001797	CDH11	cadherin 11, type 2, OB-cadherin (osteoblast)
chr18_-_24011349	0.979	NM_001792	CDH2	cadherin 2, type 1, N-cadherin (neuronal)
chr19_-_242335	0.969	NM_003712 NM_177526	PPAP2C	phosphatidic acid phosphatase type 2C
chr1_+_201711578	0.966		PRELP	proline/arginine-rich end leucine-rich repeat protein
chr10_-_79067552	0.966	NM_001014797 NM_001161352 NM_001161353 NM_002247	KCNMA1	potassium large conductance calcium-activated channel, subfamily M, alpha member 1
chr12_-_105165805	0.960	NM_006825	CKAP4	cytoskeleton-associated protein 4
chr5_-_111120817	0.957	NM_004772	C5orf13	chromosome 5 open reading frame 13
chr20_-_17986520	0.951	NM_021220	OVOL2	ovo-like 2 (Drosophila)
chr11_-_62445587	0.950	NM_000738	CHRM1	cholinergic receptor, muscarinic 1
chr17_+_67628749	0.949	NM_000346	SOX9	SRY (sex determining region Y)-box 9
chr17_-_43470134	0.949	NM_016429	COPZ2	coatomer protein complex, subunit zeta 2
chrX_+_66680593	0.948	NM_000044	AR	androgen receptor
chr11_-_64167361	0.943	NM_138734	NRXN2	neurexin 2
chr16_+_65790514	0.939	NM_024712	ELMO3	engulfment and cell motility 3
chr1_-_68470585	0.930	NM_001002292 NM_001193334 NM_024911	WLS	wntless homolog (Drosophila)
chr2_+_54537842	0.928		SPTBN1	spectrin, beta, non-erythrocytic 1
chr11_+_69165119	0.927		CCND1	cyclin D1
chr19_+_12996830	0.925		NFIX	nuclear factor I/X (CCAAT-binding transcription factor)
chr7_-_20791907	0.922
chr11_+_74629597	0.921	NM_001195528	LOC441617	hypothetical LOC441617
chr1_-_20684858	0.920		CAMK2N1	calcium/calmodulin-dependent protein kinase II inhibitor 1
chr17_+_2443983	0.917		PAFAH1B1	platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
chr11_-_132318080	0.915	NM_002545	OPCML	opioid binding protein/cell adhesion molecule-like
chr17_-_7083321	0.914	NM_024297	PHF23	PHD finger protein 23
chr11_-_72986738	0.912	NM_015159	FAM168A	family with sequence similarity 168, member A
chr10_+_71231649	0.911	NM_001130103 NM_080798 NM_080800 NM_080801 NM_080802 NM_080805	COL13A1	collagen, type XIII, alpha 1
chr17_-_959007	0.910	NM_001092	ABR	active BCR-related gene
chr5_-_73972055	0.910		ENC1	ectodermal-neural cortex 1 (with BTB-like domain)
chr9_+_33807168	0.908	NM_017811	UBE2R2	ubiquitin-conjugating enzyme E2R 2

Gene overrepresentation in process category:

enrichment	p-value	GO term	description
1.16	5.19e-29	GO:0050794	regulation of cellular process
1.15	8.33e-29	GO:0065007	biological regulation
1.43	6.16e-28	GO:0007399	nervous system development
1.15	6.37e-28	GO:0050789	regulation of biological process
1.39	1.52e-22	GO:0009653	anatomical structure morphogenesis
1.25	2.85e-22	GO:0048856	anatomical structure development
1.22	4.96e-22	GO:0032502	developmental process
1.26	7.41e-22	GO:0048731	system development
1.23	1.86e-21	GO:0007275	multicellular organismal development
1.28	1.59e-20	GO:0048522	positive regulation of cellular process
1.26	2.14e-20	GO:0048518	positive regulation of biological process
1.08	1.33e-19	GO:0009987	cellular process
1.30	2.59e-19	GO:0030154	cell differentiation
1.47	5.30e-19	GO:0022008	neurogenesis
1.29	5.68e-19	GO:0048869	cellular developmental process
1.21	7.19e-19	GO:0031323	regulation of cellular metabolic process
1.47	8.64e-18	GO:0048699	generation of neurons
1.21	5.78e-17	GO:0080090	regulation of primary metabolic process
1.28	6.94e-17	GO:0048523	negative regulation of cellular process
1.19	1.13e-16	GO:0019222	regulation of metabolic process
1.48	3.55e-15	GO:0030182	neuron differentiation
1.25	4.19e-15	GO:0048519	negative regulation of biological process
1.42	5.79e-15	GO:0048468	cell development
1.20	6.65e-15	GO:0060255	regulation of macromolecule metabolic process
1.19	8.02e-15	GO:0023052	signaling
1.30	4.81e-14	GO:0023051	regulation of signaling
1.49	1.36e-13	GO:0032989	cellular component morphogenesis
1.42	1.52e-13	GO:0051128	regulation of cellular component organization
1.54	2.84e-13	GO:0000904	cell morphogenesis involved in differentiation
1.21	3.64e-13	GO:0051171	regulation of nitrogen compound metabolic process
1.22	8.11e-13	GO:0019219	regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
1.48	1.26e-12	GO:0000902	cell morphogenesis
1.30	1.68e-12	GO:0009966	regulation of signal transduction
1.49	2.48e-12	GO:0048666	neuron development
1.18	4.32e-12	GO:0007165	signal transduction
1.16	1.19e-11	GO:0051716	cellular response to stimulus
1.51	1.25e-11	GO:0031175	neuron projection development
1.21	1.52e-11	GO:0031326	regulation of cellular biosynthetic process
1.20	2.39e-11	GO:0009889	regulation of biosynthetic process
1.25	2.93e-11	GO:0048583	regulation of response to stimulus
1.37	3.96e-11	GO:0050793	regulation of developmental process
1.21	7.58e-11	GO:2000112	regulation of cellular macromolecule biosynthetic process
1.53	8.86e-11	GO:0048667	cell morphogenesis involved in neuron differentiation
1.21	1.63e-10	GO:0010556	regulation of macromolecule biosynthetic process
1.52	2.04e-10	GO:0048812	neuron projection morphogenesis
1.43	3.43e-10	GO:0030030	cell projection organization
1.39	5.59e-10	GO:2000026	regulation of multicellular organismal development
1.35	6.65e-10	GO:0031324	negative regulation of cellular metabolic process
1.17	6.99e-10	GO:0016043	cellular component organization
1.52	8.20e-10	GO:0007409	axonogenesis
1.35	1.19e-09	GO:0010605	negative regulation of macromolecule metabolic process
1.40	1.28e-09	GO:0045595	regulation of cell differentiation
1.19	1.48e-09	GO:0071842	cellular component organization at cellular level
1.47	1.94e-09	GO:0048858	cell projection morphogenesis
1.28	2.18e-09	GO:0051239	regulation of multicellular organismal process
1.19	2.45e-09	GO:0010468	regulation of gene expression
1.16	2.56e-09	GO:0071840	cellular component organization or biogenesis
1.33	2.95e-09	GO:0006357	regulation of transcription from RNA polymerase II promoter
1.21	3.02e-09	GO:0051252	regulation of RNA metabolic process
1.46	3.19e-09	GO:0032990	cell part morphogenesis
1.29	8.36e-09	GO:0010604	positive regulation of macromolecule metabolic process
1.32	9.97e-09	GO:0009892	negative regulation of metabolic process
1.39	1.58e-08	GO:0010558	negative regulation of macromolecule biosynthetic process
1.40	1.75e-08	GO:2000113	negative regulation of cellular macromolecule biosynthetic process
1.22	2.24e-08	GO:0048513	organ development
1.27	2.30e-08	GO:0009893	positive regulation of metabolic process
1.38	3.51e-08	GO:0031327	negative regulation of cellular biosynthetic process
1.18	3.52e-08	GO:0071841	cellular component organization or biogenesis at cellular level
1.39	7.89e-08	GO:0010629	negative regulation of gene expression
1.19	1.31e-07	GO:0006355	regulation of transcription, DNA-dependent
1.36	1.32e-07	GO:0009890	negative regulation of biosynthetic process
1.37	2.26e-07	GO:0007167	enzyme linked receptor protein signaling pathway
1.60	2.43e-07	GO:0030036	actin cytoskeleton organization
1.27	3.26e-07	GO:0031325	positive regulation of cellular metabolic process
1.41	3.68e-07	GO:0045892	negative regulation of transcription, DNA-dependent
1.11	5.66e-07	GO:0043170	macromolecule metabolic process
1.39	7.47e-07	GO:0051253	negative regulation of RNA metabolic process
1.37	7.64e-07	GO:0045934	negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
1.32	8.78e-07	GO:0051173	positive regulation of nitrogen compound metabolic process
1.36	1.25e-06	GO:0051172	negative regulation of nitrogen compound metabolic process
1.12	1.32e-06	GO:0044260	cellular macromolecule metabolic process
1.40	1.42e-06	GO:0007417	central nervous system development
1.50	1.52e-06	GO:0007411	axon guidance
1.31	1.87e-06	GO:0031328	positive regulation of cellular biosynthetic process
1.32	1.87e-06	GO:0045935	positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
1.53	1.88e-06	GO:0030029	actin filament-based process
1.30	2.06e-06	GO:0009891	positive regulation of biosynthetic process
1.30	2.07e-06	GO:0006351	transcription, DNA-dependent
1.34	2.51e-06	GO:0010628	positive regulation of gene expression
1.51	2.78e-06	GO:0051130	positive regulation of cellular component organization
1.41	3.06e-06	GO:0048646	anatomical structure formation involved in morphogenesis
1.53	3.30e-06	GO:0035295	tube development
1.20	5.62e-06	GO:0007166	cell surface receptor linked signaling pathway
1.57	6.40e-06	GO:0051129	negative regulation of cellular component organization
1.31	8.87e-06	GO:0010557	positive regulation of macromolecule biosynthetic process
1.33	9.41e-06	GO:0051254	positive regulation of RNA metabolic process
1.22	1.00e-05	GO:0065009	regulation of molecular function
1.18	1.10e-05	GO:0065008	regulation of biological quality
1.09	1.26e-05	GO:0044238	primary metabolic process
1.60	1.34e-05	GO:0044087	regulation of cellular component biogenesis
1.35	1.40e-05	GO:0009887	organ morphogenesis
1.37	1.56e-05	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway
1.43	1.56e-05	GO:0000122	negative regulation of transcription from RNA polymerase II promoter
1.32	1.81e-05	GO:0009790	embryo development
1.26	2.35e-05	GO:0032879	regulation of localization
1.39	2.68e-05	GO:0051094	positive regulation of developmental process
1.25	2.82e-05	GO:0010646	regulation of cell communication
1.43	3.55e-05	GO:0043009	chordate embryonic development
1.48	3.82e-05	GO:0048729	tissue morphogenesis
1.33	5.20e-05	GO:0045893	positive regulation of transcription, DNA-dependent
1.70	5.41e-05	GO:0060537	muscle tissue development
1.42	5.52e-05	GO:0009792	embryo development ending in birth or egg hatching
1.25	6.09e-05	GO:0009605	response to external stimulus
1.45	6.98e-05	GO:0060284	regulation of cell development
1.47	8.46e-05	GO:0051270	regulation of cellular component movement
1.24	9.18e-05	GO:0010941	regulation of cell death
1.39	1.24e-04	GO:0007243	intracellular protein kinase cascade
1.39	1.24e-04	GO:0023014	signal transduction via phosphorylation event
1.72	1.26e-04	GO:0014706	striated muscle tissue development
1.48	1.38e-04	GO:0061061	muscle structure development
1.21	1.41e-04	GO:0035556	intracellular signal transduction
1.27	1.47e-04	GO:0040011	locomotion
1.43	1.69e-04	GO:0007389	pattern specification process
1.24	2.09e-04	GO:0043067	regulation of programmed cell death
1.48	2.21e-04	GO:0030334	regulation of cell migration
1.25	2.29e-04	GO:0032774	RNA biosynthetic process
1.26	2.43e-04	GO:0009888	tissue development
1.09	2.58e-04	GO:0032501	multicellular organismal process
1.08	2.64e-04	GO:0044237	cellular metabolic process
1.24	2.92e-04	GO:0042981	regulation of apoptosis
1.07	3.15e-04	GO:0008152	metabolic process
1.08	3.83e-04	GO:0050896	response to stimulus
1.63	4.19e-04	GO:0001655	urogenital system development
1.40	4.27e-04	GO:0048598	embryonic morphogenesis
1.42	4.74e-04	GO:0045597	positive regulation of cell differentiation
1.17	5.49e-04	GO:0006464	protein modification process
1.47	5.53e-04	GO:0045596	negative regulation of cell differentiation
1.47	5.53e-04	GO:2000145	regulation of cell motility
1.49	5.85e-04	GO:0003002	regionalization
1.27	5.90e-04	GO:0031399	regulation of protein modification process
1.34	8.00e-04	GO:0072358	cardiovascular system development
1.34	8.00e-04	GO:0072359	circulatory system development
1.25	9.27e-04	GO:0016265	death
1.23	9.48e-04	GO:0032268	regulation of cellular protein metabolic process
1.44	9.59e-04	GO:0040012	regulation of locomotion
1.23	1.14e-03	GO:0006793	phosphorus metabolic process
1.23	1.14e-03	GO:0006796	phosphate metabolic process
1.27	1.19e-03	GO:0006468	protein phosphorylation
1.54	1.25e-03	GO:0035239	tube morphogenesis
1.25	1.27e-03	GO:0044093	positive regulation of molecular function
1.53	1.34e-03	GO:0048732	gland development
1.38	1.46e-03	GO:0007420	brain development
1.24	1.62e-03	GO:0008219	cell death
1.44	1.77e-03	GO:0001568	blood vessel development
1.43	1.83e-03	GO:0001944	vasculature development
1.23	1.84e-03	GO:0042127	regulation of cell proliferation
1.29	1.91e-03	GO:0001932	regulation of protein phosphorylation
1.21	2.25e-03	GO:0051246	regulation of protein metabolic process
1.40	2.40e-03	GO:0051093	negative regulation of developmental process
1.50	2.75e-03	GO:0045664	regulation of neuron differentiation
1.31	2.95e-03	GO:0043068	positive regulation of programmed cell death
1.57	3.11e-03	GO:0030335	positive regulation of cell migration
1.57	3.11e-03	GO:2000147	positive regulation of cell motility
1.92	3.30e-03	GO:0048738	cardiac muscle tissue development
1.28	3.61e-03	GO:0009725	response to hormone stimulus
1.50	3.67e-03	GO:0007517	muscle organ development
1.31	4.32e-03	GO:0043065	positive regulation of apoptosis
1.68	4.49e-03	GO:0001822	kidney development
1.55	4.52e-03	GO:0051272	positive regulation of cellular component movement
1.26	4.64e-03	GO:0006915	apoptosis
1.30	5.27e-03	GO:0010942	positive regulation of cell death
1.45	5.31e-03	GO:0048568	embryonic organ development
1.57	5.41e-03	GO:0045165	cell fate commitment
1.26	6.56e-03	GO:0009719	response to endogenous stimulus
1.25	6.75e-03	GO:0012501	programmed cell death
1.38	7.04e-03	GO:0033043	regulation of organelle organization
1.45	7.15e-03	GO:0002009	morphogenesis of an epithelium
1.41	7.35e-03	GO:0051960	regulation of nervous system development
1.31	7.35e-03	GO:0045944	positive regulation of transcription from RNA polymerase II promoter
1.19	7.83e-03	GO:0050790	regulation of catalytic activity
1.54	8.51e-03	GO:0040017	positive regulation of locomotion
1.38	8.57e-03	GO:0051050	positive regulation of transport
1.30	9.16e-03	GO:0006935	chemotaxis
1.30	9.16e-03	GO:0042330	taxis
1.14	9.67e-03	GO:0090304	nucleic acid metabolic process
1.69	1.01e-02	GO:0030278	regulation of ossification
1.16	1.02e-02	GO:0016070	RNA metabolic process
1.64	1.02e-02	GO:0072001	renal system development
1.13	1.03e-02	GO:0042221	response to chemical stimulus
1.26	1.06e-02	GO:0042325	regulation of phosphorylation
1.43	1.09e-02	GO:0000165	MAPKKK cascade
1.25	1.10e-02	GO:0019220	regulation of phosphate metabolic process
1.25	1.10e-02	GO:0051174	regulation of phosphorus metabolic process
1.80	1.12e-02	GO:0001657	ureteric bud development
1.12	1.19e-02	GO:0006139	nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
1.38	1.22e-02	GO:0022603	regulation of anatomical structure morphogenesis
1.25	1.60e-02	GO:0043085	positive regulation of catalytic activity
1.32	1.66e-02	GO:0032583	regulation of gene-specific transcription
1.32	2.18e-02	GO:0008285	negative regulation of cell proliferation
1.41	2.27e-02	GO:0050767	regulation of neurogenesis
1.59	2.74e-02	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
1.28	2.96e-02	GO:0051338	regulation of transferase activity
1.57	3.07e-02	GO:0001763	morphogenesis of a branching structure
1.67	3.12e-02	GO:0030326	embryonic limb morphogenesis
1.67	3.12e-02	GO:0035113	embryonic appendage morphogenesis
1.32	3.15e-02	GO:0009968	negative regulation of signal transduction
1.50	3.30e-02	GO:0009952	anterior/posterior pattern formation
1.49	3.39e-02	GO:0051493	regulation of cytoskeleton organization
1.77	3.68e-02	GO:0042326	negative regulation of phosphorylation
1.57	3.68e-02	GO:0043254	regulation of protein complex assembly
1.15	3.75e-02	GO:0006996	organelle organization
1.52	3.84e-02	GO:0060562	epithelial tube morphogenesis
1.14	3.91e-02	GO:0043412	macromolecule modification
1.32	4.49e-02	GO:0007264	small GTPase mediated signal transduction
1.22	4.62e-02	GO:0033554	cellular response to stress
1.28	4.64e-02	GO:0007010	cytoskeleton organization
1.56	4.88e-02	GO:0010639	negative regulation of organelle organization
1.61	4.99e-02	GO:0035107	appendage morphogenesis
1.61	4.99e-02	GO:0035108	limb morphogenesis

Gene overrepresentation in compartment category:

enrichment	p-value	GO term	description
1.06	5.97e-13	GO:0044424	intracellular part
1.06	8.26e-12	GO:0005622	intracellular
1.12	1.43e-11	GO:0005634	nucleus
1.07	3.43e-10	GO:0043226	organelle
1.07	3.80e-10	GO:0043229	intracellular organelle
1.07	1.80e-07	GO:0043231	intracellular membrane-bounded organelle
1.07	2.27e-07	GO:0005737	cytoplasm
1.07	2.28e-07	GO:0043227	membrane-bounded organelle
1.41	3.45e-06	GO:0045202	synapse
1.32	9.34e-06	GO:0030054	cell junction
1.79	1.66e-05	GO:0005925	focal adhesion
1.02	1.68e-05	GO:0044464	cell part
1.02	1.84e-05	GO:0005623	cell
1.49	4.19e-05	GO:0016323	basolateral plasma membrane
1.72	6.97e-05	GO:0030055	cell-substrate junction
1.73	7.80e-05	GO:0005924	cell-substrate adherens junction
1.37	1.00e-04	GO:0043005	neuron projection
1.15	2.72e-04	GO:0005829	cytosol
1.16	3.58e-04	GO:0031981	nuclear lumen
1.14	6.47e-04	GO:0044459	plasma membrane part
1.55	8.63e-04	GO:0005912	adherens junction
1.39	8.92e-04	GO:0044456	synapse part
1.18	1.51e-03	GO:0005654	nucleoplasm
1.37	3.94e-03	GO:0015629	actin cytoskeleton
1.47	4.14e-03	GO:0031252	cell leading edge
1.13	4.34e-03	GO:0044428	nuclear part
1.22	4.38e-03	GO:0031982	vesicle
2.00	5.66e-03	GO:0000781	chromosome, telomeric region
1.22	7.96e-03	GO:0031410	cytoplasmic vesicle
1.47	8.27e-03	GO:0070161	anchoring junction
2.07	9.10e-03	GO:0042641	actomyosin
1.12	1.18e-02	GO:0043233	organelle lumen
1.15	1.20e-02	GO:0005856	cytoskeleton
1.22	1.28e-02	GO:0016023	cytoplasmic membrane-bounded vesicle
1.22	1.29e-02	GO:0031988	membrane-bounded vesicle
1.46	1.50e-02	GO:0030136	clathrin-coated vesicle
2.09	1.72e-02	GO:0032432	actin filament bundle
1.43	1.77e-02	GO:0030424	axon
1.41	1.78e-02	GO:0030135	coated vesicle
1.92	2.33e-02	GO:0043679	axon terminus
1.90	2.36e-02	GO:0044306	neuron projection terminus
1.11	2.45e-02	GO:0070013	intracellular organelle lumen
1.65	3.16e-02	GO:0033267	axon part
1.11	3.89e-02	GO:0031974	membrane-enclosed lumen

Gene overrepresentation in function category:

enrichment	p-value	GO term	description
1.14	8.87e-23	GO:0005515	protein binding
1.07	2.69e-17	GO:0005488	binding
1.43	2.70e-12	GO:0043565	sequence-specific DNA binding
1.34	4.82e-12	GO:0030528	transcription regulator activity
1.34	2.01e-11	GO:0001071	nucleic acid binding transcription factor activity
1.34	2.01e-11	GO:0003700	sequence-specific DNA binding transcription factor activity
1.38	3.62e-07	GO:0008092	cytoskeletal protein binding
1.46	3.27e-06	GO:0003779	actin binding
1.26	3.79e-04	GO:0019899	enzyme binding
1.40	8.44e-04	GO:0008134	transcription factor binding
1.48	1.30e-03	GO:0010843	promoter binding
1.32	1.49e-03	GO:0019904	protein domain specific binding
1.47	1.79e-03	GO:0000975	regulatory region DNA binding
1.47	1.79e-03	GO:0001067	regulatory region nucleic acid binding
1.47	1.79e-03	GO:0044212	transcription regulatory region DNA binding
1.33	4.70e-03	GO:0000988	protein binding transcription factor activity
1.33	4.70e-03	GO:0000989	transcription factor binding transcription factor activity
1.13	5.70e-03	GO:0003677	DNA binding
1.32	6.33e-03	GO:0003712	transcription cofactor activity
1.35	6.95e-03	GO:0016563	transcription activator activity